Randomized, double‐blind, pilot evaluation of intravenous glutathione in Parkinson's disease

Hauser, Robert A., Lyons, Kelly E., McClain, Terry, Carter, Summer, Perlmutter, David·2009·Movement Disorders
DOI 10.1002/mds.22401

Cited by (143)

Items 101–143 of 143

  1. Nutritional dietary supplementation of d-ribose-l-cysteine ameliorates altered sperm parameters, hormone profile and testicular histomorphology in highly active antiretroviral therapy induced toxicity in adult male Wistar rat
    Babatunde Ogunlade, Victor Okoliko Ukwenya, Sunday Aderemi Adelakun, Toluwase Solomon Olawuyi · 2020 · PharmaNutrition
  2. The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic and PRKN/PINK1 -mediated Parkinson’s disease – a large-scale targeted metabolomics study
    Alexander Balck, Max Borsche, Philip Campbell, Xi Luo, John Harvey, Theresa Brückmann, Charlotte Ludwig, Amy C. Harms, Katja Lohmann, Huw R. Morris et al. · 2024 · medRxiv
  3. The role of N-acetylcysteine and glutathione in the management of Parkinson’s disease: a systematic review of oxidative biomarkers and clinical outcomes
    Imran Mohammed, Yasimin Nankya, U. Teng Hong, Amy Kan, Alya Masoud Abdelhafid, Gladys Oluyemisi Latunde-Dada · 2026 · Amino Acids
  4. ALSUntangled No. 52: Glutathione
    THE ALSUNTANGLED GROUP · 2019 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  5. Anti-oxidants in astrocytes as target of neuroprotection for Parkinson’s disease
    Masato Asanuma, Ikuko Miyazaki · 2020 · Folia Pharmacologica Japonica
  6. Symptomatic vs. Disease-Modifying Therapies
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  7. The role of Glutathione as an adjunct therapy in the treatment of patients with COVID-19-Related Acute Respiratory Syndrome
    Taís Mazzini Setti · 2021 · Advance Research Journal of medical clinical and science
  8. pH-Dependent Oxidase- and Hydrolase-Mimicking Activity of Nanoceria and Its Composite with Nitrogen-Doped Carbon Quantum Dots for Sensitive Detection of Dopamine, Glutathione, and Methyl Paraoxon
    Yogyata Chawre, Manmohan Lal Satnami, Ankita Beena Kujur, Akash Sinha, Prince Kumar Soni, Pinki Miri, Rekha Nagwanshi, Indrapal Karbhal, Kallol Kumar Ghosh · 2026 · ACS Chemical Neuroscience
  9. The Rotenone Model of Parkinson's Disease in Studying the Mechanisms of Nigrostriatal Cell Death
    Omar M. E. Abdel‐Salam · 2015
  10. Disease Subtypes: The Promise and the Fallacy
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  11. Antioxidant Use in Humans – Successes and Failures
    Hironobu Eguchi, Haruhiko Sakiyama, Daisaku Yoshihara, Noriko Fujiwara, Keiichiro Suzuki · 2014 · Springer eBooks
  12. Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy
    Sharon Hausman-Cohen, Carol Bilich, Sandeep Kapoor, Eduardo Maristany, Anne Stefani, Alexandra Wilcox · 2022 · Frontiers in Aging Neuroscience
  13. Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
    Indrani Datta, Aishwarya Raj, Alka Kaushal · 2022 · Springer eBooks
  14. Role of dietary antioxidants and redox status in Parkinson's disease
    Reza Amani, Sanaz Mehrabani · 2023 · Elsevier eBooks
  15. Nutritional Supplementation, Diet, and Genetics and Their Impact on Parkinson’s Disease (PD), a Review of Studies
    Steven P Petrosino · 2014 · Journal of Nutritional Health & Food Engineering
  16. Potential Therapies for Mitochondrial Dysfunction
    Claire Henchcliffe, M. Flint Beal · 2011 · Springer eBooks
  17. A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease
    Vignayanandam Ravindernath Muddapu, Karthik Vijayakumar, Keerthiga Ramakrishnan, V. Srinivasa Chakravarthy · 2020 · arXiv (Cornell University)
  18. Reply: Intravenous glutathione in Parkinson's disease
    Robert A. Hauser, Kelly E. Lyons · 2010 · Movement Disorders
  19. Assessing the Toxic Load and Detoxification Strategies
    Len Wisneski, Joseph E. Pizzorno · 2017 · Routledge eBooks
  20. The Hypothesis That Refuses to Die
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  21. References
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  22. Our Living Dissonance
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  23. Disease “Redefinition”: A Tough Pill to Swallow
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  24. The Fault in Our Models
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  25. The Shaky Six and the “Second Reality”
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  26. Predictions for the 2020s and Beyond
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  27. The Scientific and Lay Narratives
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  28. Note Added at Press Time – Reviving LOF
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  29. Preface 1 – The Question
    Alberto Javier Espay, Benjamin Stecher · 2020
  30. Challenges Viewed from Afar
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  31. Epilogue
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  32. The Moonshot: Population-Based Studies of Aging
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  33. Preface 2 – Enter Patient
    Alberto Javier Espay, Benjamin Stecher · 2020
  34. Lessons from Oncology
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  35. Pieces of a Puzzle?
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  36. Biomarkers: The Promise and the Fallacy
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  37. Protein Paradox
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  38. Index
    Alberto Javier Espay, Benjamin Stecher · 2020 · Cambridge University Press eBooks
  39. Parkinson Disease
    Adam D. Simmons · 2012 · Elsevier eBooks
  40. Assessing the Toxic Load and Detoxification Strategies
    Joseph E. Pizzorno · 2017 · CRC Press eBooks
  41. Dairy consumption and the risk of Parkinson's disease
    Randa S. Hasan, Hagar F. Forsan · 2024 · Elsevier eBooks
  42. Potentiel thérapeutique de neurones dopaminergiques dérivés de cellules souches embryonnaires de souris dans un modèle murin de la maladie de Parkinson
    Sandie Brisson · 2017
  43. Glutathione Supplementation in Parenteral Nutrition to Prevent Oxidative Stress Related Complications in Preterm Infants: A Narrative Review of Preclinical Efficacy and Safety Profile
    Jean‐Claude Lavoie, Ibrahim Mohamed · 2026 · Nutrients